Related Experiment Video
Updated: Aug 5, 2025

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Binding mechanism of anacardic acid, carnosol and garcinol with PCAF: A comprehensive study using molecular docking
Ramakrishnan Jaganathan1, Poomani Kumaradhas1
1Laboratory of Biocrystallography and Computational Molecular Biology, Department of Physics, Periyar University, Salem, India.
Abstract:
The p300/CBP associated factor bromodomain (PCAF Brd) is emerged as one of the promising target proteins for different types of cancers. PCAF is one among the histone acetyltransferase enzymes which involved in the regulation of transcriptase process by modifying the chromatin structure. Anacardic acid, carnosol, garcinol are the experimentally reported inhibitors of PCAF Brd; however, their detailed binding mechanism these inhibitors are not yet known. The intermolecular interaction, binding energy, and the stability of these inhibitors with the active site of PCAF Brd are playing the key role in the binding of these inhibitors with PCAF. The in silico study incorporates the molecular docking and dynamics simulations; these molecular level simulations allow to understand the binding mechanism. In the present study, the induced fit molecular docking and molecular dynamics of anacardic acid, carnosol and garcinol molecules against the PCAF Brd have been performed. The docking score values of these molecules are -5.112 (anacardic acid), -5.141 (carnosol), -5.199 (garcinol) and -3.641 (L45) kcal/mol, respectively. Further, the molecular dynamics simulation was carried out for these docked complexes to understand their conformational their stability and binding energy from the roots means square deviation (RMSD) and root means square of fluctuation (RMSF), and molecular mechanics with the generalized born and surface area solvation (MM/GBSA) binding free energy calculations. The intermolecular interactions and binding free energy values confirm that garcinol forms key interactions and has high binding affinity towards PCAF Brd on compare with the other two inhibitors. Therefore, garcinol may be considered as a potential inhibitor of PCAF Brd.
Insights
Garcinol shows strong binding affinity to PCAF bromodomain, a promising cancer target. This study used molecular docking and dynamics to reveal garcinol
Area of Science:
- Biochemistry and Molecular Biology
- Cancer Research
- Computational Chemistry
Background:
- The p300/CBP associated factor bromodomain (PCAF Brd) is a key target in cancer therapy.
- Histone acetyltransferase PCAF regulates transcription by modifying chromatin structure.
- Known PCAF Brd inhibitors like anacardic acid, carnosol, and garcinol lack detailed binding mechanism understanding.
Purpose of the Study:
- To investigate the binding mechanisms of anacardic acid, carnosol, and garcinol with PCAF Brd using in silico methods.
- To determine the binding affinity and stability of these inhibitors within the PCAF Brd active site.
- To identify the most potent inhibitor among the tested compounds for PCAF Brd.
Main Methods:
- Induced fit molecular docking was performed for anacardic acid, carnosol, and garcinol against PCAF Brd.
- Molecular dynamics simulations were conducted on the docked complexes.
- Binding free energy calculations were performed using MM/GBSA, alongside RMSD and RMSF analyses.
Main Results:
- Docking scores indicated varying affinities: -5.112 (anacardic acid), -5.141 (carnosol), and -5.199 (garcinol) kcal/mol.
- Molecular dynamics simulations assessed complex stability and conformational changes.
- Garcinol demonstrated superior intermolecular interactions and higher binding affinity to PCAF Brd compared to anacardic acid and carnosol.
Conclusions:
- Garcinol exhibits significant binding affinity and key interactions with the PCAF Brd active site.
- Garcinol is identified as a potential therapeutic inhibitor for PCAF Brd.
- Further research into garcinol as a PCAF Brd inhibitor is warranted for cancer treatment strategies.
Related Concept Videos
The Equilibrium Binding Constant and Binding Strength
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Acidity of Carboxylic Acids
Ligand Binding and Linkage
Lipids as Anchors
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
Physical Properties of Carboxylic Acids

